Automated description from the Alliance of Genome Resources (Release 3.2)
Predicted to have DNA-binding transcription repressor activity, RNA polymerase II-specific; RNA polymerase II cis-regulatory region sequence-specific DNA binding activity; and protein homodimerization activity. Involved in positive regulation of NF-kappaB transcription factor activity. Predicted to localize to cytosol and plasma membrane. Orthologous to human LRRFIP1 (LRR binding FLII interacting protein 1).